IRADIMED CORPORATION Announces Dismissal of Appeal
October 30 2015 - 7:30AM
iRadimed Corporation (NASDAQ:IRMD), the only known provider of
non-magnetic intravenous (IV) infusion pump systems that are
designed to be safe for use during magnetic resonance imaging (MRI)
procedures, announced today that with regards to the Lam Civil
Action matter, the U.S. Court of Appeals for the Eleventh Circuit,
on joint motion of the parties, dismissed with prejudice the
plaintiff’s appeal from the May 26, 2015 dismissal of all claims by
the U.S. District Court for the Southern District of Florida.
About iRadimed Corporation
iRadimed Corporation is the only known provider of non-magnetic
intravenous (“IV”) infusion pump systems that are designed to be
safe for use during magnetic resonance imaging (“MRI”) procedures.
Other electromechanical medical devices and pumps contain magnetic
and electronic parts that are potentially dangerous to operate in
the presence of the powerful magnet that drives an MRI. Our MRidium
3860+ MRI compatible IV infusion pump system has been designed with
non-ferrous parts, ceramic ultrasonic motors, non-magnetic mobile
stands and other special features in order to safely and
predictably deliver anesthesia and other IV fluids during various
MRI procedures. Our pump solution provides a seamless approach to
providing IV fluids before, during and after an MRI scan, which is
important to critically-ill patients who cannot be removed from
their vital medications, and children and infants who must
generally be sedated in order to remain immobile during an MRI
scan.
MRidium is a trademark of iRadimed Corporation.
For more information please visit www.iradimed.com.
Media Contact:
Chris Scott
Chief Financial Officer
iRadimed Corporation
(407) 677-8022
InvestorRelations@iradimed.com
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
iRadimed (NASDAQ:IRMD)
Historical Stock Chart
From Sep 2023 to Sep 2024